The Patent Finder

Dynamic Monitoring of Activation of G-Protein Coupled Receptor (GPCR) and Receptor Tyrosine Kinase (RTK) in Living Cells Using Real-Time Microelectronic Cell Sensing Technology

Agilent Technologies, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/191,684, filed Sep 11, 2008. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 8,263,375Dynamic Monitoring of Activation of G-Protein Coupled Receptor (GPCR) and Receptor Tyrosine Kinase (RTK) in Living Cells Using Real-Time Microelectronic Cell Sensing Technology
In force
 · High confidence
Agilent Technologies, Inc.In force
High confidence
US 10,012,636Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution
In force
 · Medium confidence
Agilent Technologies, Inc.In force
Medium confidence
US 10,533,985Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution
In force
 · Medium confidence
Agilent Technologies, Inc.In force
Medium confidence
US 11,360,072Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution
In force
 · Medium confidence
Agilent Technologies, Inc.In force
Medium confidence
US 11,906,508Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution
In force
 · High confidence
Agilent Technologies, Inc.In force
High confidence
US 9,612,234Data Analysis of Impedance-Based Cardiomyocyte-Beating Signals as Detected on Real-Time Cell Analysis (RTCA) Cardio Instruments
In force
 · Medium confidence
Agilent Technologies, Inc.In force
Medium confidence
US 9,709,548Label-Free Monitoring of Excitation-Contraction Coupling and Excitable Cells Using Impedance Based Systems with Millisecond Time Resolution
In force
 · Medium confidence
Agilent Technologies, Inc.In force
Medium confidence
US 8,921,041Device and Method for Electroporation-Based Delivery of Molecules into Cells and Dynamic Monitoring of Cell Responses
Lapsed Dec 30, 2022 on the fee record
Ended Dec 30, 2022 · Medium confidence
Agilent Technologies, Inc.Lapsed Dec 30, 2022 on the fee recordEnded Dec 30, 2022
Medium confidence
US 10,067,121Dynamic Montioring of G-Protein Coupled Receptor (GPCR) and Receptor Tyrosine Kinase (RTK) Activity and Pathways in Living Cells Using Real-Time Microelectronic Cell Sensing Technology
Term ended · USPTO later recorded non-payment Oct 12, 2026
Term ended Jul 18, 2023 · Medium confidence
Agilent Technologies, Inc.Term ended
USPTO later recorded non-payment Oct 12, 2026
Term ended Jul 18, 2023
Medium confidence
US 10,168,318A Method of Measuring Cell-Substrate Impedance in Living Cells to Identify Compounds Affecting Receptor Tyrosine Kinase (RTK) Activity and Pathways
Term ended
Ended no later than Jul 18, 2023 · Medium confidence
Agilent Technologies, Inc.Term endedEnded no later than Jul 18, 2023
Medium confidence
29 more patents in this group · Pro
10 of 39 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 39, including 26 expired.
Upgrade to Pro
7 of these are in force and held by Agilent Technologies, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited